B cells responses and cytokine production are regulated by their immune microenvironment

Cytokine

Volumn 74, Issue 2, 2015, Pages 318-326

  Vazquez, Monica I ^a   Catalan Dibene, Jovani ^a   Zlotnik, Albert ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

B cells; Chemokines; Cytokines; Interferon; Interleukins

Indexed keywords

ALPHA INTERFERON; BETA INTERFERON; CD5 ANTIGEN; CHEMOKINE; CHEMOKINE CCL28; CHEMOKINE RECEPTOR CCR10; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 14; INTERLEUKIN 4; INTERLEUKIN 6; INTERLEUKIN 7; INTERLEUKIN 7 RECEPTOR ALPHA; UNCLASSIFIED DRUG; CYTOKINE;

ADAPTIVE IMMUNITY; ANTIBODY PRODUCTION; ANTIGEN EXPRESSION; B LYMPHOCYTE; CELL RENEWAL; CELL SURVIVAL; CYTOKINE PRODUCTION; CYTOKINE RELEASE; HUMAN; IMMUNOGLOBULIN PRODUCTION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE MIGRATION; LYMPHOCYTE PROLIFERATION; MICROENVIRONMENT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; IMMUNOLOGY; PATHOLOGY; TUMOR MICROENVIRONMENT;

ANIMALS; ANTIBODY FORMATION; B-LYMPHOCYTES; CELLULAR MICROENVIRONMENT; CYTOKINES; HUMANS; LYMPHOCYTE ACTIVATION;

EID: 84937872746     PISSN: 10434666     EISSN: 10960023     Source Type: Journal    
DOI: 10.1016/j.cyto.2015.02.007     Document Type: Review

References (130)

1. Janeway C.A., Medzhitov R. Innate immune recognition. Annu Rev Immunol 2002, 20:197-216.
2. Hoffmann J.A. The immune response of Drosophila. Nature 2003, 426:33-38.
3. Akira S., Uematsu S., Takeuchi O. Pathogen recognition and innate immunity. Cell 2006, 124:783-801.
4. Cooper M.D., Alder M.N. The evolution of adaptive immune systems. Cell 2006, 124:815-822.
5. Conticello S.G., Thomas C.J., Petersen-Mahrt S.K., Neuberger M.S. Evolution of the AID/APOBEC family of polynucleotide (deoxy)cytidine deaminases. Mol Biol Evol 2005, 22:367-377.
6. Brack C., Hirama M., Lenhard-Schuller R., Tonegawa S. A complete immunoglobulin gene is created by somatic recombination. Cell 1978, 15:1-14.
7. Nutt S.L., Heavey B., Rolink A.G., Busslinger M. Commitment to the B-lymphoid lineage depends on the transcription factor Pax5. Nature 1999, 401:556-562.
8. LeBien T.W., Tedder T.F. B lymphocytes: how they develop and function. Blood 2008, 112:1570-1580.
9. Lam K.P., Kuhn R., Rajewsky K. In vivo ablation of surface immunoglobulin on mature B cells by inducible gene targeting results in rapid cell death. Cell 1997, 90:1073-1083.
10. Illera V.A., Perandones C.E., Stunz L.L., Mower D.A., Mower D.A., Ashman R.F. Apoptosis in splenic B lymphocytes. Regulation by protein kinase C and IL-4. J Immunol 1993, 151:2965-2973.
11. Jacob J., Kelsoe G., Rajewsky K., Weiss U. Intraclonal generation of antibody mutants in germinal centres. Nature 1991, 354:389-392.
12. Cerutti A., Cols M., Puga I. Marginal zone B cells: virtues of innate-like antibody-producing lymphocytes. Nat Rev Immunol 2013, 13:118-132.
13. Pillai S., Cariappa A. The follicular versus marginal zone B lymphocyte cell fate decision. Nat Rev Immunol 2009, 9:767-777.
14. Radbruch A., Muehlinghaus G., Luger E.O., Inamine A., Smith K.G., Dorner T., et al. Competence and competition: the challenge of becoming a long-lived plasma cell. Nat Rev Immunol 2006, 6:741-750.
15. Dorshkind K., Montecino-Rodriguez E. Fetal B-cell lymphopoiesis and the emergence of B-1-cell potential. Nat Rev Immunol 2007, 7:213-219.
16. Hardy R.R. B-1 B cell development. J Immunol 2006, 177:2749-2754.
17. Haas K.M., Poe J.C., Steeber D.A., Tedder T.F. B-1a and B-1b cells exhibit distinct developmental requirements and have unique functional roles in innate and adaptive immunity to S. pneumoniae. Immunity 2005, 23:7-18.
18. Alugupalli K.R., Leong J.M., Woodland R.T., Muramatsu M., Honjo T., Gerstein R.M. B1b lymphocytes confer T cell-independent long-lasting immunity. Immunity 2004, 21:379-390.
19. Hayakawa K., Hardy R.R., Parks D.R., Herzenberg L.A. The "Ly-1 B" cell subpopulation in normal immunodefective, and autoimmune mice. J Exp Med 1983, 157:202-218.
20. Hardy R.R., Hayakawa K. B cell development pathways. Annu Rev Immunol 2001, 19:595-621.
21. Hever A., Roth R.B., Hevezi P., Marin M.E., Acosta J.A., Acosta H., et al. Human endometriosis is associated with plasma cells and overexpression of B lymphocyte stimulator. Proc Natl Acad Sci USA 2007, 104:12451-12456.
22. Cooper M.D., Peterson R.D., South M.A., Good R.A. The functions of the thymus system and the bursa system in the chicken. 1966. J Immunol 2006, 176:6370-6404.
23. Bouaziz J.D., Yanaba K., Venturi G.M., Wang Y., Tisch R.M., Poe J.C., et al. Therapeutic B cell depletion impairs adaptive and autoreactive CD4+ T cell activation in mice. Proc Natl Acad Sci USA 2007, 104:20878-20883.
24. Mackay F., Woodcock S.A., Lawton P., Ambrose C., Baetscher M., Schneider P., et al. Mice transgenic for BAFF develop lymphocytic disorders along with autoimmune manifestations. J Exp Med 1999, 190:1697-1710.
25. Baumgarth N., Jager G.C., Herman O.C., Herzenberg L.A. CD4+ T cells derived from B cell-deficient mice inhibit the establishment of peripheral B cell pools. Proc Natl Acad Sci USA 2000, 97:4766-4771.
26. Gonnella P.A., Waldner H.P., Weiner H.L. B cell-deficient (mu MT) mice have alterations in the cytokine microenvironment of the gut-associated lymphoid tissue (GALT) and a defect in the low dose mechanism of oral tolerance. J Immunol 2001, 166:4456-4464.
27. Yang X., Brunham R.C. Gene knockout B cell-deficient mice demonstrate that B cells play an important role in the initiation of T cell responses to Chlamydia trachomatis (mouse pneumonitis) lung infection. J Immunol 1998, 161:1439-1446.
28. Brocker C., Thompson D., Matsumoto A., Nebert D.W., Vasiliou V. Evolutionary divergence and functions of the human interleukin (IL) gene family. Hum Genomics 2010, 5:30-55.
29. Dinarello C.A., Mier J.W. Interleukins. Annu Rev Med 1986, 37:173-178.
30. Clavel G., Thiolat A., Boissier M.C. Interleukin newcomers creating new numbers in rheumatology: IL-34 to IL-38. Joint, Bone, Spine : Revue du Rhumatisme 2013, 80:449-453.
31. van de Veerdonk F.L., Stoeckman A.K., Wu G., Boeckermann A.N., Azam T., Netea M.G., et al. IL-38 binds to the IL-36 receptor and has biological effects on immune cells similar to IL-36 receptor antagonist. Proc Natl Acad Sci USA 2012, 109:3001-3005.
32. Ushach I., Burkhardt A.M., Martinez C., Hevezi P.A., Gerber P.A., Buhren B.A., et al. METEORIN-LIKE is a cytokine associated with barrier tissues and alternatively activated macrophages. Clin Immunol 2014.
33. Boraschi D., Lucchesi D., Hainzl S., Leitner M., Maier E., Mangelberger D., et al. IL-37: a new anti-inflammatory cytokine of the IL-1 family. Eur Cytokine Netw 2011, 22:127-147.
34. Namen A.E., Schmierer A.E., March C.J., Overell R.W., Park L.S., Urdal D.L., et al. B cell precursor growth-promoting activity. Purification and characterization of a growth factor active on lymphocyte precursors. J Exp Med 1988, 167:988-1002.
35. Goodwin R.G., Lupton S., Schmierer A., Hjerrild K.J., Jerzy R., Clevenger W., et al. Human interleukin 7: molecular cloning and growth factor activity on human and murine B-lineage cells. Proc Natl Acad Sci USA 1989, 86:302-306.
36. Namen A.E., Lupton S., Hjerrild K., Wignall J., Mochizuki D.Y., Schmierer A., et al. Stimulation of B-cell progenitors by cloned murine interleukin-7. Nature 1988, 333:571-573.
37. von Freeden-Jeffry U., Vieira P., Lucian L.A., McNeil T., Burdach S.E., Murray R. Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine. J Exp Med 1995, 181:1519-1526.
38. Peschon J.J., Morrissey P.J., Grabstein K.H., Ramsdell F.J., Maraskovsky E., Gliniak B.C., et al. Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice. J Exp Med 1994, 180:1955-1960.
39. Grabstein K.H., Waldschmidt T.J., Finkelman F.D., Hess B.W., Alpert A.R., Boiani N.E., et al. Inhibition of murine B and T lymphopoiesis in vivo by an anti-interleukin 7 monoclonal antibody. J Exp Med 1993, 178:257-264.
40. Chao D.T., Korsmeyer S.J. BCL-2 family: regulators of cell death. Annu Rev Immunol 1998, 16:395-419.
41. Namikawa R., Muench M.O., de Vries J.E., Roncarolo M.G. The FLK2/FLT3 ligand synergizes with interleukin-7 in promoting stromal-cell-independent expansion and differentiation of human fetal pro-B cells in vitro. Blood 1996, 87:1881-1890.
42. Puel A., Ziegler S.F., Buckley R.H., Leonard W.J. Defective IL7R expression in T(-)B(+)NK(+) severe combined immunodeficiency. Nat Genet 1998, 20:394-397.
43. Mazzucchelli R., Durum S.K. Interleukin-7 receptor expression: intelligent design. Nat Rev Immunol 2007, 7:144-154.
44. Lange K., Gold M.M., et al. Autoantibodies in human glomerulonephritis. J Clin Investig 1949, 28:50-55.
45. Wei C., Zeff R., Goldschneider I. Murine pro-B cells require IL-7 and its receptor complex to up-regulate IL-7R alpha, terminal deoxynucleotidyltransferase, and c mu expression. J Immunol 2000, 164:1961-1970.
46. Corcoran A.E., Smart F.M., Cowling R.J., Crompton T., Owen M.J., Venkitaraman A.R. The interleukin-7 receptor alpha chain transmits distinct signals for proliferation and differentiation during B lymphopoiesis. EMBO J 1996, 15:1924-1932.
47. Scheeren F.A., van Lent A.U., Nagasawa M., Weijer K., Spits H., Legrand N., et al. Thymic stromal lymphopoietin induces early human B-cell proliferation and differentiation. Eur J Immunol 2010, 40:955-965.
48. Hashimoto Y., Montecino-Rodriguez E., Leathers H., Stephan R.P., Dorshkind K. B-cell development in the thymus is limited by inhibitory signals from the thymic microenvironment. Blood 2002, 100:3504-3511.
49. Han S., Dillon S.R., Zheng B., Shimoda M., Schlissel M.S., Kelsoe G. V(D)J recombinase activity in a subset of germinal center B lymphocytes. Science 1997, 278:301-305.
50. Papavasiliou F., Casellas R., Suh H., Qin X.F., Besmer E., Pelanda R., et al. V(D)J recombination in mature B cells: a mechanism for altering antibody responses. Science 1997, 278:298-301.
51. Hikida M., Nakayama Y., Yamashita Y., Kumazawa Y., Nishikawa S.I., Ohmori H. Expression of recombination activating genes in germinal center B cells: involvement of interleukin 7 (IL-7) and the IL-7 receptor. J Exp Med 1998, 188:365-372.
52. Paul W.E. Interleukin 4/B cell stimulatory factor 1: one lymphokine, many functions. FASEB J: Official Publ Fed Am Soc Exp Biol 1987, 1:456-461.
53. Nelms K., Keegan A.D., Zamorano J., Ryan J.J., Paul W.E. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 1999, 17:701-738.
54. Idzerda R.L., March C.J., Mosley B., Lyman S.D., Vanden Bos T., Gimpel S.D., et al. Human interleukin 4 receptor confers biological responsiveness and defines a novel receptor superfamily. J Exp Med 1990, 171:861-873.
55. Chomarat P., Banchereau J. An update on interleukin-4 and its receptor. Eur Cytokine Netw 1997, 8:333-344.
56. Rush J.S., Hodgkin P.D. B cells activated via CD40 and IL-4 undergo a division burst but require continued stimulation to maintain division, survival and differentiation. Eur J Immunol 2001, 31:1150-1159.
57. Vella A., Teague T.K., Ihle J., Kappler J., Marrack P. Interleukin 4 (IL-4) or IL-7 prevents the death of resting T cells: stat6 is probably not required for the effect of IL-4. J Exp Med 1997, 186:325-330.
58. Paul W.E. Interleukin 4: signalling mechanisms and control of T cell differentiation. Ciba Found Symp 1997, 204:208-216. discussion 16-9.
59. Thieu V.T., Nguyen E.T., McCarthy B.P., Bruns H.A., Kapur R., Chang C.H., et al. IL-4-stimulated NF-kappaB activity is required for Stat6 DNA binding. J Leukoc Biol 2007, 82:370-379.
60. Wurster A.L., Rodgers V.L., White M.F., Rothstein T.L., Grusby M.J. Interleukin-4-mediated protection of primary B cells from apoptosis through Stat6-dependent up-regulation of Bcl-xL. J Biol Chem 2002, 277:27169-27175.
61. Takeda K., Tanaka T., Shi W., Matsumoto M., Minami M., Kashiwamura S., et al. Essential role of Stat6 in IL-4 signalling. Nature 1996, 380:627-630.
62. Kaplan M.H., Schindler U., Smiley S.T., Grusby M.J. Stat6 is required for mediating responses to IL-4 and for development of Th2 cells. Immunity 1996, 4:313-319.
63. Howard M., Farrar J., Hilfiker M., Johnson B., Takatsu K., Hamaoka T., et al. Identification of a T cell-derived b cell growth factor distinct from interleukin 2. J Exp Med 1982, 155:914-923.
64. Steinke J.W., Borish L. Th2 cytokines and asthma. Interleukin-4: its role in the pathogenesis of asthma, and targeting it for asthma treatment with interleukin-4 receptor antagonists. Respir Res 2001, 2:66-70.
65. Van Snick J. Interleukin-6: an overview. Annu Rev Immunol 1990, 8:253-278.
66. Hirano T., Yasukawa K., Harada H., Taga T., Watanabe Y., Matsuda T., et al. Complementary DNA for a novel human interleukin (BSF-2) that induces B lymphocytes to produce immunoglobulin. Nature 1986, 324:73-76.
67. Paludan S.R. Requirements for the induction of interleukin-6 by herpes simplex virus-infected leukocytes. J Virol 2001, 75:8008-8015.
68. Matsukura S., Kokubu F., Noda H., Tokunaga H., Adachi M. Expression of IL-6, IL-8, and RANTES on human bronchial epithelial cells, NCI-H292, induced by influenza virus A. J Allergy Clin Immunol 1996, 98:1080-1087.
69. Eggesbo J.B., Hjermann I., Hostmark A.T., Kierulf P. LPS induced release of IL-1 beta, IL-6, IL-8 and TNF-alpha in EDTA or heparin anticoagulated whole blood from persons with high or low levels of serum HDL. Cytokine 1996, 8:152-160.
70. Beurel E., Jope R.S. Lipopolysaccharide-induced interleukin-6 production is controlled by glycogen synthase kinase-3 and STAT3 in the brain. J Neuroinflammation 2009, 6:9.
71. Hirano T., Taga T., Nakano N., Yasukawa K., Kashiwamura S., Shimizu K., et al. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci USA 1985, 82:5490-5494.
72. Okuda Y., Sakoda S., Bernard C.C., Fujimura H., Saeki Y., Kishimoto T., et al. IL-6-deficient mice are resistant to the induction of experimental autoimmune encephalomyelitis provoked by myelin oligodendrocyte glycoprotein. Int Immunol 1998, 10:703-708.
73. Samoilova E.B., Horton J.L., Hilliard B., Liu T.S., Chen Y. IL-6-deficient mice are resistant to experimental autoimmune encephalomyelitis: roles of IL-6 in the activation and differentiation of autoreactive T cells. J Immunol 1998, 161:6480-6486.
74. Eugster H.P., Frei K., Kopf M., Lassmann H., Fontana A. IL-6-deficient mice resist myelin oligodendrocyte glycoprotein-induced autoimmune encephalomyelitis. Eur J Immunol 1998, 28:2178-2187.
75. Bao Y., Cao X. The immune potential and immunopathology of cytokine-producing B cell subsets: a comprehensive review. J Autoimmun 2014, 55C:10-23.
76. Tanaka Y., Saito K., Shirakawa F., Ota T., Suzuki H., Eto S., et al. Production of B cell-stimulating factors by B cells in patients with systemic lupus erythematosus. J Immunol 1988, 141:3043-3049.
77. Yoshizaki K., Matsuda T., Nishimoto N., Kuritani T., Taeho L., Aozasa K., et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 1989, 74:1360-1367.
78. de Waal Malefyt R., Abrams J., Bennett B., Figdor C.G., de Vries J.E. Interleukin 10(IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med 1991, 174:1209-1220.
79. Fiorentino D.F., Zlotnik A., Mosmann T.R., Howard M., O'Garra A. IL-10 inhibits cytokine production by activated macrophages. J Immunol 1991, 147:3815-3822.
80. Isler P., de Rochemonteix B.G., Songeon F., Boehringer N., Nicod L.P. Interleukin-12 production by human alveolar macrophages is controlled by the autocrine production of interleukin-10. Am J Respir Cell Mol Biol 1999, 20:270-278.
81. Corinti S., Albanesi C., la Sala A., Pastore S., Girolomoni G. Regulatory activity of autocrine IL-10 on dendritic cell functions. J Immunol 2001, 166:4312-4318.
82. Iyer S.S., Cheng G. Role of interleukin 10 transcriptional regulation in inflammation and autoimmune disease. Crit Rev Immunol 2012, 32:23-63.
83. Kuhn R., Lohler J., Rennick D., Rajewsky K., Muller W. Interleukin-10-deficient mice develop chronic enterocolitis. Cell 1993, 75:263-274.
84. Sellon R.K., Tonkonogy S., Schultz M., Dieleman L.A., Grenther W., Balish E., et al. Resident enteric bacteria are necessary for development of spontaneous colitis and immune system activation in interleukin-10-deficient mice. Infect Immun 1998, 66:5224-5231.
85. Saraiva M., O'Garra A. The regulation of IL-10 production by immune cells. Nat Rev Immunol 2010, 10:170-181.
86. Suda T., O'Garra A., MacNeil I., Fischer M., Bond M.W., Zlotnik A. Identification of a novel thymocyte growth-promoting factor derived from B cell lymphomas. Cell Immunol 1990, 129:228-240.
87. Yanaba K., Bouaziz J.D., Haas K.M., Poe J.C., Fujimoto M., Tedder T.F. A regulatory B cell subset with a unique CD1dhiCD5+ phenotype controls T cell-dependent inflammatory responses. Immunity 2008, 28:639-650.
88. Maseda D., Candando K.M., Smith S.H., Kalampokis I., Weaver C.T., Plevy S.E., et al. Peritoneal cavity regulatory B cells (B10 cells) modulate IFN-gamma+CD4+ T cell numbers during colitis development in mice. J Immunol 2013, 191:2780-2795.
89. Blair P.A., Norena L.Y., Flores-Borja F., Rawlings D.J., Isenberg D.A., Ehrenstein M.R., et al. CD19(+)CD24(hi)CD38(hi) B cells exhibit regulatory capacity in healthy individuals but are functionally impaired in systemic Lupus Erythematosus patients. Immunity 2010, 32:129-140.
90. Rosser E.C., Oleinika K., Tonon S., Doyle R., Bosma A., Carter N.A., et al. Regulatory B cells are induced by gut microbiota-driven interleukin-1beta and interleukin-6 production. Nat Med 2014, 20:1334-1339.
91. Maseda D., Smith S.H., DiLillo D.J., Bryant J.M., Candando K.M., Weaver C.T., et al. Regulatory B10 cells differentiate into antibody-secreting cells after transient IL-10 production in vivo. J Immunol 2012, 188:1036-1048.
92. Evans J.G., Chavez-Rueda K.A., Eddaoudi A., Meyer-Bahlburg A., Rawlings D.J., Ehrenstein M.R., et al. Novel suppressive function of transitional 2 B cells in experimental arthritis. J Immunol 2007, 178:7868-7878.
93. Spencer N.F., Daynes R.A. IL-12 directly stimulates expression of IL-10 by CD5+ B cells and IL-6 by both CD5+ and CD5- B cells: possible involvement in age-associated cytokine dysregulation. Int Immunol 1997, 9:745-754.
94. Brummel R., Lenert P. Activation of marginal zone B cells from lupus mice with type A(D) CpG-oligodeoxynucleotides. J Immunol 2005, 174:2429-2434.
95. Schroder K., Hertzog P.J., Ravasi T., Hume D.A. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol 2004, 75:163-189.
96. Taniguchi T., Takaoka A. The interferon-alpha/beta system in antiviral responses: a multimodal machinery of gene regulation by the IRF family of transcription factors. Curr Opin Immunol 2002, 14:111-116.
97. Lu B., Ebensperger C., Dembic Z., Wang Y., Kvatyuk M., Lu T., et al. Targeted disruption of the interferon-gamma receptor 2 gene results in severe immune defects in mice. Proc Natl Acad Sci USA 1998, 95:8233-8238.
98. Cantin E., Tanamachi B., Openshaw H. Role for gamma interferon in control of herpes simplex virus type 1 reactivation. J Virol 1999, 73:3418-3423.
99. Giroux M., Schmidt M., Descoteaux A. IFN-gamma-induced MHC class II expression: transactivation of class II transactivator promoter IV by IFN regulatory factor-1 is regulated by protein kinase C-alpha. J Immunol 2003, 171:4187-4194.
100. Demengeot J., Vasconcellos R., Modigliani Y., Grandien A., Coutinho A. B lymphocyte sensitivity to IgM receptor ligation is independent of maturation stage and locally determined by macrophage-derived IFN-beta. Int Immunol 1997, 9:1677-1685.
101. Braun D., Caramalho I., Demengeot J. IFN-alpha/beta enhances BCR-dependent B cell responses. Int Immunol 2002, 14:411-419.
102. Gujer C., Sandgren K.J., Douagi I., Adams W.C., Sundling C., Smed-Sorensen A., et al. IFN-alpha produced by human plasmacytoid dendritic cells enhances T cell-dependent naive B cell differentiation. J Leukoc Biol 2011, 89:811-821.
103. Bradley L.M., Dalton D.K., Croft M. A direct role for IFN-gamma in regulation of Th1 cell development. J Immunol 1996, 157:1350-1358.
104. Abed N.S., Chace J.H., Fleming A.L., Cowdery J.S. Interferon-gamma regulation of B lymphocyte differentiation: activation of B cells is a prerequisite for IFN-gamma-mediated inhibition of B cell differentiation. Cell Immunol 1994, 153:356-366.
105. Johnson-Leger C., Hasbold J., Holman M., Klaus G.G. The effects of IFN-gamma on CD40-mediated activation of B cells from X-linked immunodeficient or normal mice. J Immunol 1997, 159:1150-1159.
106. Kawano Y., Noma T., Yata J. Regulation of human IgG subclass production by cytokines. IFN-gamma and IL-6 act antagonistically in the induction of human IgG1 but additively in the induction of IgG2. J Immunol 1994, 153:4948-4958.
107. Finkelman F.D., Katona I.M., Mosmann T.R., Coffman R.L. IFN-gamma regulates the isotypes of Ig secreted during in vivo humoral immune responses. J Immunol 1988, 140:1022-1027.
108. Wang W., Soto H., Oldham E.R., Buchanan M.E., Homey B., Catron D., et al. Identification of a novel chemokine (CCL28), which binds CCR10 (GPR2). J Biol Chem 2000, 275:22313-22323.
109. Pan J., Kunkel E.J., Gosslar U., Lazarus N., Langdon P., Broadwell K., et al. A novel chemokine ligand for CCR10 and CCR3 expressed by epithelial cells in mucosal tissues. J Immunol 2000, 165:2943-2949.
110. Liu G.X., Lan J., Sun Y., Hu Y.J., Jiang G.S. Expression of the chemokine CCL28 in pleomorphic adenoma and adenolymphoma of the human salivary glands. Exp Ther Med 2012, 4:65-69.
111. Hanamoto H., Nakayama T., Miyazato H., Takegawa S., Hieshima K., Tatsumi Y., et al. Expression of CCL28 by Reed-Sternberg cells defines a major subtype of classical Hodgkin's disease with frequent infiltration of eosinophils and/or plasma cells. Am J Pathol 2004, 164:997-1006.
112. Hernandez-Molina G., Burkhardt A.M., Lima G., Zlotnik A., Betanzos J.L., Bahena S., et al. Absence of salivary CCL28 in primary Sjogren's syndrome. Rheumatol Int 2015.
113. Wilson E., Butcher E.C. CCL28 controls immunoglobulin (Ig)A plasma cell accumulation in the lactating mammary gland and IgA antibody transfer to the neonate. J Exp Med 2004, 200:805-809.
114. Morteau O., Gerard C., Lu B., Ghiran S., Rits M., Fujiwara Y., et al. An indispensable role for the chemokine receptor CCR10 in IgA antibody-secreting cell accumulation. J Immunol 2008, 181:6309-6315.
115. Kunkel E.J., Kim C.H., Lazarus N.H., Vierra M.A., Soler D., Bowman E.P., et al. CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells. J Clin Investig 2003, 111:1001-1010.
116. Hennighausen L., Robinson G.W. Information networks in the mammary gland. Nat Rev Mol Cell Biol 2005, 6:715-725.
117. Pope S.M., Zimmermann N., Stringer K.F., Karow M.L., Rothenberg M.E. The eotaxin chemokines and CCR3 are fundamental regulators of allergen-induced pulmonary eosinophilia. J Immunol 2005, 175:5341-5350.
118. Scanlon K.M., Hawksworth R.J., Lane S.J., Mahon B.P. IL-17A induces CCL28, supporting the chemotaxis of IgE-secreting B cells. Int Arch Allergy Immunol 2011, 156:51-61.
119. Ghadially H., Ross X.L., Kerst C., Dong J., Reske-Kunz A.B., Ross R. Differential regulation of CCL22 gene expression in murine dendritic cells and B cells. J Immunol 2005, 174:5620-5629.
120. Nakayama T., Hieshima K., Nagakubo D., Sato E., Nakayama M., Kawa K., et al. Selective induction of Th2-attracting chemokines CCL17 and CCL22 in human B cells by latent membrane protein 1 of Epstein-Barr virus. J Virol 2004, 78:1665-1674.
121. Takegawa S., Jin Z., Nakayama T., Oyama T., Hieshima K., Nagakubo D., et al. Expression of CCL17 and CCL22 by latent membrane protein 1-positive tumor cells in age-related Epstein-Barr virus-associated B-cell lymphoproliferative disorder. Cancer Sci 2008, 99:296-302.
122. Scala G., Kuang Y.D., Hall R.E., Muchmore A.V., Oppenheim J.J. Accessory cell function of human B cells. I. Production of both interleukin 1-like activity and an interleukin 1 inhibitory factor by an EBV-transformed human B cell line. J Exp Med 1984, 159:1637-1652.
123. Matsushima K., Procopio A., Abe H., Scala G., Ortaldo J.R., Oppenheim J.J. Production of interleukin 1 activity by normal human peripheral blood B lymphocytes. J Immunol 1985, 135:1132-1136.
124. Paul C.C., Keller J.R., Armpriester J.M., Baumann M.A. Epstein-Barr virus transformed B lymphocytes produce interleukin-5. Blood 1990, 75:1400-1403.
125. Lund F.E. Cytokine-producing B lymphocytes-key regulators of immunity. Curr Opin Immunol 2008, 20:332-338.
126. Harris D.P., Haynes L., Sayles P.C., Duso D.K., Eaton S.M., Lepak N.M., et al. Reciprocal regulation of polarized cytokine production by effector B and T cells. Nat Immunol 2000, 1:475-482.
127. Duddy M.E., Alter A., Bar-Or A. Distinct profiles of human B cell effector cytokines: a role in immune regulation?. J Immunol 2004, 172:3422-3427.
128. Duddy M., Niino M., Adatia F., Hebert S., Freedman M., Atkins H., et al. Distinct effector cytokine profiles of memory and naive human B cell subsets and implication in multiple sclerosis. J Immunol 2007, 178:6092-6099.
129. Luu V.P., Vazquez M.I., Zlotnik A. B cells participate in tolerance and autoimmunity through cytokine production. Autoimmunity 2014, 47:1-12.
130. Kao D., Lux A., Schwab I., Nimmerjahn F. Targeting B cells and autoantibodies in the therapy of autoimmune diseases. Semin Immunopathol 2014, 36:289-299.